Cleaver Leaves has announced it will be supporting The University of Missouri by providing CBD isolate at no cost.
Clever Leaves, a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids with operations and investments in the United States, Canada, Colombia, Germany and Portugal, is supporting The University of Missouri’s translational peadiatric neuroscience lab by providing CBD isolate product at no cost for an upcoming National Institutes of Health proposal.
The focus of the translational studies at the University is to analyse whether CBD is an effective treatment and disease-modifying therapy for neurodevelopmental disorders.
Supporting cannabis research
Clever Leaves will provide a certificate of analysis confirming the product contents and purity in accordance with applicable standards. The project will be one of the first sponsored research partnerships under Clever Leaves’ recently announced Project Change Lives Campaign.
For the campaign, the Company has pledged to contribute up to $25m retail value of medical cannabis products to any eligible US organisation in order to help advance scientific research into the medical benefits of cannabinoids.
Clever Leaves CEO, Kyle Detwiler, commented: “As one of the first sponsored research partnerships under Clever Leaves’ new Project Change Lives campaign, it is important that we partner with a highly credentialed university and research team such as the University of Missouri to validate our strong commitment to advancing the understanding of medical cannabis domestically by providing our pharmaceutical-grade cannabinoids to researchers in the US.
“The basic and clinical research findings emerging from The University of Missouri’s Child Neurology Division are aimed at providing the foundational knowledge on which many of medicine’s next generation of treatment options could be developed. Accordingly, this ongoing research is directly in-line with Clever Leaves’ goal to change lives through the research and development of new cannabis therapies.”
This is the second research team supported for a proposal under Clever Leaves’ Project Change Lives Campaign, following an initial sponsored study that was announced in collaboration with UC Davis’ Plant Sciences Department.
[activecampaign form=31]
